MedTrace Logo

CD0104 VEST II Post Marketing Surveillance Study

NCT02332330 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2016-04-28

No results posted yet for this study

Summary

This study is designed to collect post market data on use of the VEST, particularly on saphenous vein grafts to the right territory of the heart.

Conditions

  • Coronary Artery Bypass Surgery

Interventions

DEVICE

VEST

Sponsors & Collaborators

  • Vascular Graft Solutions Ltd.

    lead INDUSTRY

Principal Investigators

  • David P Taggart, Professor · Oxford University Hospitals NHS Trust

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2016-01-31
Completion
2016-04-30

Countries

  • Germany
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02332330 on ClinicalTrials.gov